Health Condition 1: I679- Cerebrovascular disease, unspecified Health Condition 2: N189- Chronic kidney disease, unspecified Health Condition 3: F028- Dementia in other diseases classified elsewhere Health Condition 4: I10- Essential (primary) hypertension Health Condition 5: G- Mental Health Health Condition 6: E118- Type 2 diabetes mellitus with unspecified complications
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
National Institute on Aging (NIA) under the National Institute of Health, USA
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 40 years and more at baseline living in the urban areas of Delhi and Chennai
Exclusion criteria
Exclusion criteria: Pregnant women and bed-ridden individuals
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In preliminary studies, it has successfully demonstrated the feasibility of administering novel AI-enabled digital cognitive assessment tools, collecting and processing plasma AD biomarkers, and pilot standardization of MRI neuroimaging biomarkers. This study will advance progress in understanding the natural history of the AD/ADRD along the life course and promote early detection, precise diagnosis and tailored therapeutic strategies for this high-risk, understudied population and beyond.Timepoint: This study is a 5 year observational cohort study; so the outcome will be assessed after the completion of five years. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Sailesh Mohan
Centre for Chronic Disease Control
Outcome results
None listed